banner

A new way of investing

MARKETS

Volatile session ends with decent gains
(15:33, 19 May 2020)

back
Key-benchmark-indices-ended-with-decent-gains-on-Tuesday,-tracking-positive-Asian-shares-amid-optimism-about-a-potential-vaccine-for-the-coronavirus.-Domestic-shares-also-witnessed-bargain-hunting-after-the-Sensex-and-the-Nifty-lost-about-6%-in-the-past-three-session.-However,-gains-were-capped-due-to-rising-coronavirus-cases-in-India.-

As-per-provisional-closing,-the-barometer-S&P-BSE-Sensex-rose-167.19-points-or-0.56%-at-30,196.17.-The-Nifty-50-index-gained-64.45-points-or-0.73%-at-8,887.70.

The-Nifty-opened-higher-at-8,961.70-and-hit-fresh-intraday-high-of-9,030.35-in-morning-trade.-Selling-emerged-at-higher-level-which-dragged-the-index-to-the-day's-low-of-8,855.30-in-mid-afternoon-trade.-

The-broader-market-was-mixed.-The-S&P-BSE-Mid-Cap-index-was-up-0.52%-while-the-S&P-BSE-Small-Cap-index-fell-0.2%.

The-market-breadth-was-negative.-On-the-BSE,-1028-shares-rose-and-1262-shares-fell.-A-total-of-170-shares-were-unchanged.

COVID-19-Update:

Total-COVID-19-confirmed-cases-worldwide-stood-at-48,04,167-far-with-3,18,527-deaths.-India-reported-58,802-active-cases-of-COVID-19-infection-and-3,163-deaths,-according-to-the-data-from-the-Ministry-of-Health-and-Family-Welfare,-Government-of-India.

In-a-bid-to-contain-the-spread-of-the-novel-coronavirus-pandemic,-the-Centre-on-17-May-2020-extended-the-nationwide-lockdown-till-31-May-2020.

Buzzing-Index:

The-Nifty-Bank-index-declined-0.56%-to-17,474.85,-extending-its-losing-run-to-fourth-consecutive-trading-session.-The-index-has-slumped-11%-in-four-trading-days-from-its-previous-closing-high-of-19,634.95-on-13-May-2020.

Bank-of-Baroda-(down-5.18%),-Bandhan-Bank-(down-3.92%),-Federal-Bank-(down-3.16%),-Punjab-National-Bank-(down-2.56%),-IndusInd-Bank-(down-2.24%),-SBI-(down-1.55%),-Axis-Bank-(down-1.09%),-IDFC-First-Bank-(down-0.76%)-and-HDFC-Bank-(down-0.73%)-were-top-losers-in-bank-index.

Q4-Results-Today:

Bajaj-Finance-(up-1.02%),-Apollo-Tyres-(up-0.11%),-Tata-Power-Co.-(up-1.6%)-and-Ujjivan-Small-Finance-Bank-(up-1.15%)-are-some-of-the-companies-that-will-announce-their-quarterly-results-today.

Earnings-Impact:

Bharti-Airtel-jumped-10.9%.-The-telecom-major-reported-a-consolidated-net-loss-of-₹-5327-crore-in-Q4-March-2020-(Q4-FY20)-as-against-net-profit-of-₹-107.20-crore-in-Q4-March-2019-(Q4-FY19).-The-company-took-a-hit-due-to-an-exceptional-item-of-₹-7,004-crore-in-the-quarter,-which-comprises-mainly-of-a-charge-on-account-of-reassessment-of-regulatory-cost-based-on-a-recent-judgment-on-one-time-spectrum-charge-(OTSC)-related-matter.

Net-sales-jumped-15.1%-to-₹-23,722.70-crore-during-the-period-under-review.-EBITDA-rose-51.7%-to-₹-10,326-crore-in-Q4-FY20-over-Q4-FY19.-EBITDA-margin-stood-at-43.5%-as-on-31-March-2020-as-compared-to-33%-as-on-31-March-2019.

The-company-said-its-average-revenue-per-user-(ARPU)-rose-25.20%-to-₹-154-in-Q4-FY20-from-₹-123-in-Q4-FY19.-Growth-was-broad-based-and-all-segments-registered-healthy-underlying-growth,-the-company-said.-The-company-total-customer-base-increased-by-4.9%-to-42.3-crore-customers-in-Q4-March-2020-from-40.3-crore-customers-in-Q4-March-2019.

Gabriel-India-hit-an-upper-circuit-of-5%-at-₹-73.50-after-net-profit-jumped-53.72%-to-₹-26.58-crore-on-a-16.78%-fall-in-revenue-from-operations-to-₹-424.64-crore-in-Q4-March-2020-over-Q4-March-2019.-Total-expenses-falling-16.78%-to-₹-405.46-crore,-profit-before-tax-(PBT)-contracted-13.22%-to-₹-22.33-crore-in-Q4-FY20-over-Q4-FY19.-The-result-was-announced-during-market-hours-today.-The-company's-profitability-was-aided-by-lower-tax-expense.-Current-tax-expenditure-shrunk-50.93%-to-₹-5.45-crore-in-Q4-FY20-from-₹-11.12-crore-in-Q4-FY19.

Astrazeneca-Pharma-India-slumped-10.6%-after-net-profit-declined-2.4%-to-₹-9.58-crore-on-2.4%-increase-in-net-sales-to-₹-194.90-crore-in-Q4-March-2020-over-Q4-March-2019.-Profit-before-tax-stood-at-₹-13.35-crore-in-Q4-March-2020,-rising-57.6%-year-on-year-from-₹-8.47-crore-in-Q4-March-2019.-The-result-was-announced-after-market-hours-yesterday,-18-May-2020.

Torrent-Power-rose-2.38%.-The-company-reported-consolidated-net-loss-of-₹-273.94-crore-in-Q4-March-2020-compared-with-net-profit-of-₹-24.80-crore-in-Q4-March-2019.-The-company-has-provided-impairment-loss-of-₹-1,000-crore-as-exceptional-item-during-the-quarter-towards-carrying-cost-of-DGEN-plant-(Dahej,-Gujarat).-Net-sales-rose-2%-to-₹-2,983.50-crore-in-Q4-March-2020-over-Q4-March-2019.-EBITDA-grew-15%-to-₹-864-crore-in-Q4-March-2020-as-compared-to-₹-750-crore-in-Q4-March-2019.

Stocks-in-Spotlight:

Biocon-gained-1.36%.-The-drug-maker-said-that-its-subsidiary-Biocon-Biologics-India-has-received-the-certificate-of-Good-Manufacturing-Practice-(GMP)-compliance-from-EMA-for-multiple-Biologics-Drug-Substance-(DS)-and-Drug-Product-(DP)-manufacturing-facilities-at-Biocon-Park,-Bengaluru.-These-facilities-are-used-for-the-manufacture-of-DS-and-DP-for-Biosimilars:-Bevacizumab,-Trastuzumab,-Pegfilgrastim-and-secondary-packaging-of-Insulin-Glargine-for-EU-markets,-and-were-inspected-in-March-2020,-Biocon-said.

KEC-International-gained-2.59%-after-the-company-secured-new-orders-of-₹-1,203-crore-across-its-various-businesses.-The-firm-has-secured-a-transmission-and-distribution-order-of-₹-917-crore-for-T&D-projects-in-India,-Bangladesh,-Africa-and-the-Americas.-The-company's-civil-business-secured-orders-of-₹-176-crore-for-industrial-[civil-works-for-Flue-Gas-Desulfurization-(FGD)-project]-and-residential-projects-in-India.-While-cable-business-secured-order-of-₹-110-crore-for-various-types-of-cables-and-cabling-projects.

Lupin-was-down-2.36%.-The-drug-major-announced-the-launch-of-authorized-generic-version-of-Bausch-Health's-Apriso-(mesalamine-extended-release-capsules-0.375-g)-in-the-US.-Mesalamine-extended-release-capsules-0.375g-(authorized-generic-version)-are-indicated-for-the-maintenance-of-remission-of-ulcerative-colitis-in-patients-18-years-of-age-and-older.-Mesalamine-extended-release-capsules-0.375-g,-RLD:-Apriso-had-an-annual-sales-of-approximately-$290-million-in-the-US-(IQVIA-MAT-March-2020).

Global-Markets:

European-markets-were-trading-lower-amid-profit-booking-after-Monday's-rally.-Asian-markets-closed-higher-as-hopes-rise-on-a-potential-coronavirus-vaccine-after-a-positive-development-from-a-Moderna-trial.

Moderna-reported-'positive'-phase-one-results-for-a-potential-coronavirus-vaccine.-The-company-said-that-after-two-doses-all-45-trial-participants-had-developed-coronavirus-antibodies.

Meanwhile,-Chinese-President-Xi-Jinping-said-Monday-that-his-country-will-provide-$2-billion-over-two-years-to-help-other-countries-combat-the-impact-of-the-coronavirus-pandemic.

US-stocks-rose-sharply-on-Monday-on-optimism-that-the-American-economy-might-be-percolating-again,-while-the-medical-community-works-toward-a-potential-COVID-19-vaccine.

Stock-market-bulls-also-gained-confidence-following-remarks-by-the-U.S.-central-bank-chief-Powell-on-Sunday-and-Monday-that-the-Fed-would-continue-to-support-the-economy-and-financial-markets-through-the-viral-outbreak.

Powered-by-Capital-Market---Live-News

Key-benchmark-indices-ended-with-decent-gains-on-Tuesday,-tracking-positive-Asian-shares-amid-optimism-about-a-potential-vaccine-for-the-coronavirus.-Domestic-shares-also-witnessed-bargain-hunting-after-the-Sensex-and-the-Nifty-lost-about-6%-in-the-past-three-session.-However,-gains-were-capped-due-to-rising-coronavirus-cases-in-India.-

As-per-provisional-closing,-the-barometer-S&P-BSE-Sensex-rose-167.19-points-or-0.56%-at-30,196.17.-The-Nifty-50-index-gained-64.45-points-or-0.73%-at-8,887.70.

The-Nifty-opened-higher-at-8,961.70-and-hit-fresh-intraday-high-of-9,030.35-in-morning-trade.-Selling-emerged-at-higher-level-which-dragged-the-index-to-the-day's-low-of-8,855.30-in-mid-afternoon-trade.-

The-broader-market-was-mixed.-The-S&P-BSE-Mid-Cap-index-was-up-0.52%-while-the-S&P-BSE-Small-Cap-index-fell-0.2%.

The-market-breadth-was-negative.-On-the-BSE,-1028-shares-rose-and-1262-shares-fell.-A-total-of-170-shares-were-unchanged.

COVID-19-Update:

Total-COVID-19-confirmed-cases-worldwide-stood-at-48,04,167-far-with-3,18,527-deaths.-India-reported-58,802-active-cases-of-COVID-19-infection-and-3,163-deaths,-according-to-the-data-from-the-Ministry-of-Health-and-Family-Welfare,-Government-of-India.

In-a-bid-to-contain-the-spread-of-the-novel-coronavirus-pandemic,-the-Centre-on-17-May-2020-extended-the-nationwide-lockdown-till-31-May-2020.

Buzzing-Index:

The-Nifty-Bank-index-declined-0.56%-to-17,474.85,-extending-its-losing-run-to-fourth-consecutive-trading-session.-The-index-has-slumped-11%-in-four-trading-days-from-its-previous-closing-high-of-19,634.95-on-13-May-2020.

Bank-of-Baroda-(down-5.18%),-Bandhan-Bank-(down-3.92%),-Federal-Bank-(down-3.16%),-Punjab-National-Bank-(down-2.56%),-IndusInd-Bank-(down-2.24%),-SBI-(down-1.55%),-Axis-Bank-(down-1.09%),-IDFC-First-Bank-(down-0.76%)-and-HDFC-Bank-(down-0.73%)-were-top-losers-in-bank-index.

Q4-Results-Today:

Bajaj-Finance-(up-1.02%),-Apollo-Tyres-(up-0.11%),-Tata-Power-Co.-(up-1.6%)-and-Ujjivan-Small-Finance-Bank-(up-1.15%)-are-some-of-the-companies-that-will-announce-their-quarterly-results-today.

Earnings-Impact:

Bharti-Airtel-jumped-10.9%.-The-telecom-major-reported-a-consolidated-net-loss-of-₹-5327-crore-in-Q4-March-2020-(Q4-FY20)-as-against-net-profit-of-₹-107.20-crore-in-Q4-March-2019-(Q4-FY19).-The-company-took-a-hit-due-to-an-exceptional-item-of-₹-7,004-crore-in-the-quarter,-which-comprises-mainly-of-a-charge-on-account-of-reassessment-of-regulatory-cost-based-on-a-recent-judgment-on-one-time-spectrum-charge-(OTSC)-related-matter.

Net-sales-jumped-15.1%-to-₹-23,722.70-crore-during-the-period-under-review.-EBITDA-rose-51.7%-to-₹-10,326-crore-in-Q4-FY20-over-Q4-FY19.-EBITDA-margin-stood-at-43.5%-as-on-31-March-2020-as-compared-to-33%-as-on-31-March-2019.

The-company-said-its-average-revenue-per-user-(ARPU)-rose-25.20%-to-₹-154-in-Q4-FY20-from-₹-123-in-Q4-FY19.-Growth-was-broad-based-and-all-segments-registered-healthy-underlying-growth,-the-company-said.-The-company-total-customer-base-increased-by-4.9%-to-42.3-crore-customers-in-Q4-March-2020-from-40.3-crore-customers-in-Q4-March-2019.

Gabriel-India-hit-an-upper-circuit-of-5%-at-₹-73.50-after-net-profit-jumped-53.72%-to-₹-26.58-crore-on-a-16.78%-fall-in-revenue-from-operations-to-₹-424.64-crore-in-Q4-March-2020-over-Q4-March-2019.-Total-expenses-falling-16.78%-to-₹-405.46-crore,-profit-before-tax-(PBT)-contracted-13.22%-to-₹-22.33-crore-in-Q4-FY20-over-Q4-FY19.-The-result-was-announced-during-market-hours-today.-The-company's-profitability-was-aided-by-lower-tax-expense.-Current-tax-expenditure-shrunk-50.93%-to-₹-5.45-crore-in-Q4-FY20-from-₹-11.12-crore-in-Q4-FY19.

Astrazeneca-Pharma-India-slumped-10.6%-after-net-profit-declined-2.4%-to-₹-9.58-crore-on-2.4%-increase-in-net-sales-to-₹-194.90-crore-in-Q4-March-2020-over-Q4-March-2019.-Profit-before-tax-stood-at-₹-13.35-crore-in-Q4-March-2020,-rising-57.6%-year-on-year-from-₹-8.47-crore-in-Q4-March-2019.-The-result-was-announced-after-market-hours-yesterday,-18-May-2020.

Torrent-Power-rose-2.38%.-The-company-reported-consolidated-net-loss-of-₹-273.94-crore-in-Q4-March-2020-compared-with-net-profit-of-₹-24.80-crore-in-Q4-March-2019.-The-company-has-provided-impairment-loss-of-₹-1,000-crore-as-exceptional-item-during-the-quarter-towards-carrying-cost-of-DGEN-plant-(Dahej,-Gujarat).-Net-sales-rose-2%-to-₹-2,983.50-crore-in-Q4-March-2020-over-Q4-March-2019.-EBITDA-grew-15%-to-₹-864-crore-in-Q4-March-2020-as-compared-to-₹-750-crore-in-Q4-March-2019.

Stocks-in-Spotlight:

Biocon-gained-1.36%.-The-drug-maker-said-that-its-subsidiary-Biocon-Biologics-India-has-received-the-certificate-of-Good-Manufacturing-Practice-(GMP)-compliance-from-EMA-for-multiple-Biologics-Drug-Substance-(DS)-and-Drug-Product-(DP)-manufacturing-facilities-at-Biocon-Park,-Bengaluru.-These-facilities-are-used-for-the-manufacture-of-DS-and-DP-for-Biosimilars:-Bevacizumab,-Trastuzumab,-Pegfilgrastim-and-secondary-packaging-of-Insulin-Glargine-for-EU-markets,-and-were-inspected-in-March-2020,-Biocon-said.

KEC-International-gained-2.59%-after-the-company-secured-new-orders-of-₹-1,203-crore-across-its-various-businesses.-The-firm-has-secured-a-transmission-and-distribution-order-of-₹-917-crore-for-T&D-projects-in-India,-Bangladesh,-Africa-and-the-Americas.-The-company's-civil-business-secured-orders-of-₹-176-crore-for-industrial-[civil-works-for-Flue-Gas-Desulfurization-(FGD)-project]-and-residential-projects-in-India.-While-cable-business-secured-order-of-₹-110-crore-for-various-types-of-cables-and-cabling-projects.

Lupin-was-down-2.36%.-The-drug-major-announced-the-launch-of-authorized-generic-version-of-Bausch-Health's-Apriso-(mesalamine-extended-release-capsules-0.375-g)-in-the-US.-Mesalamine-extended-release-capsules-0.375g-(authorized-generic-version)-are-indicated-for-the-maintenance-of-remission-of-ulcerative-colitis-in-patients-18-years-of-age-and-older.-Mesalamine-extended-release-capsules-0.375-g,-RLD:-Apriso-had-an-annual-sales-of-approximately-$290-million-in-the-US-(IQVIA-MAT-March-2020).

Global-Markets:

European-markets-were-trading-lower-amid-profit-booking-after-Monday's-rally.-Asian-markets-closed-higher-as-hopes-rise-on-a-potential-coronavirus-vaccine-after-a-positive-development-from-a-Moderna-trial.

Moderna-reported-'positive'-phase-one-results-for-a-potential-coronavirus-vaccine.-The-company-said-that-after-two-doses-all-45-trial-participants-had-developed-coronavirus-antibodies.

Meanwhile,-Chinese-President-Xi-Jinping-said-Monday-that-his-country-will-provide-$2-billion-over-two-years-to-help-other-countries-combat-the-impact-of-the-coronavirus-pandemic.

US-stocks-rose-sharply-on-Monday-on-optimism-that-the-American-economy-might-be-percolating-again,-while-the-medical-community-works-toward-a-potential-COVID-19-vaccine.

Stock-market-bulls-also-gained-confidence-following-remarks-by-the-U.S.-central-bank-chief-Powell-on-Sunday-and-Monday-that-the-Fed-would-continue-to-support-the-economy-and-financial-markets-through-the-viral-outbreak.

Powered-by-Capital-Market---Live-News